Clinical Trial Update: Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating the role of midodrine and tolvaptan in patients with cirrhosis and refractory or recurrent ascites.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis

Drugs mentioned

• Midodrine (Midodrine)
• tolvaptan (tolvaptan)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Cirrhosis, Refractory/Recurrent Ascites | Phase 2, Phase 3 | Status: COMPLETED